Immune-related adverse events associated with immune checkpoint blockade
MA Postow, R Sidlow… - New England Journal of …, 2018 - Mass Medical Soc
Side Effects of Immune Checkpoint Blockade The wide range of immune-related adverse
effects associated with immune checkpoint blockade can complicate this effective therapy …
effects associated with immune checkpoint blockade can complicate this effective therapy …
Myasthenia gravis: subgroup classification and therapeutic strategies
NE Gilhus, JJ Verschuuren - The Lancet Neurology, 2015 - thelancet.com
Myasthenia gravis is an autoimmune disease that is characterised by muscle weakness and
fatigue, is B-cell mediated, and is associated with antibodies directed against the …
fatigue, is B-cell mediated, and is associated with antibodies directed against the …
Single-cell eQTL map** identifies cell type–specific genetic control of autoimmune disease
The human immune system displays substantial variation between individuals, leading to
differences in susceptibility to autoimmune disease. We present single-cell RNA sequencing …
differences in susceptibility to autoimmune disease. We present single-cell RNA sequencing …
Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations
L Dresser, R Wlodarski, K Rezania… - Journal of clinical medicine, 2021 - mdpi.com
Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective
transmission at the neuromuscular junction. The incidence of the disease is 4.1 to 30 cases …
transmission at the neuromuscular junction. The incidence of the disease is 4.1 to 30 cases …
Regulatory T cells in the treatment of disease
Regulatory T (Treg) cells suppress inflammation and regulate immune system activity. In
patients with systemic or organ-specific autoimmune diseases or those receiving …
patients with systemic or organ-specific autoimmune diseases or those receiving …
Regulatory T cells in multiple sclerosis and myasthenia gravis
KM Danikowski, S Jayaraman… - Journal of …, 2017 - Springer
Multiple sclerosis (MS) is a chronic debilitating disease of the central nervous system
primarily mediated by T lymphocytes with specificity to neuronal antigens in genetically …
primarily mediated by T lymphocytes with specificity to neuronal antigens in genetically …
[HTML][HTML] The epidemiology of myasthenia gravis
AM Bubuioc, A Kudebayeva… - Journal of medicine …, 2021 - ncbi.nlm.nih.gov
Neuromuscular junction (NMJ) disorders include several dysfunctions that ultimately lead to
muscle weakness. Myasthenia gravis (MG) is the most prevalent NMJ disorder with a highly …
muscle weakness. Myasthenia gravis (MG) is the most prevalent NMJ disorder with a highly …
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants
Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of
melanocytes, with epidemiological association with other autoimmune diseases. In previous …
melanocytes, with epidemiological association with other autoimmune diseases. In previous …
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
Myasthenia gravis is a chronic autoimmune disease characterized by autoantibody-
mediated interference of signal transmission across the neuromuscular junction. We …
mediated interference of signal transmission across the neuromuscular junction. We …
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society
Myasthenia gravis (MG) is an autoimmune antibody-mediated disorder of neuromuscular
synaptic transmission. The clinical hallmark of MG consists of fluctuating fatigability and …
synaptic transmission. The clinical hallmark of MG consists of fluctuating fatigability and …